FDA.reportPublic FDA data

betamethasone valerate 1.2 MG/ML [Luxiq]

RxCUI
1244635
RxNorm name
betamethasone valerate 1.2 MG/ML [Luxiq]
Term type
SBDC
Status
Active
Updated
2026-09-09 14:39:06

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
032012
Active start
032012
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
1.2 MG / 1 MLbetamethasone

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
betamethasone1514

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRbetamethasone valerate 1.2 MG/ML [Luxiq]1NAMES
RxNorm Namebetamethasone valerate 1.2 MG/ML [Luxiq]1NAMES
TTYSBDC1ATTRIBUTES
RxCUI12446351CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC05AACorticosteroidsATC1-4betamethasone
ATCS03BACorticosteroidsATC1-4betamethasone
ATCS02BACorticosteroidsATC1-4betamethasone
ATCR01ADCorticosteroidsATC1-4betamethasone
ATCA07EACorticosteroids acting locallyATC1-4betamethasone
ATCS01BACorticosteroids, plainATC1-4betamethasone
ATCD07ACCorticosteroids, potent (group III)ATC1-4betamethasone
ATCD07XCCorticosteroids, potent, other combinationsATC1-4betamethasone
ATCS01CBCorticosteroids/antiinfectives/mydriatics in combinationATC1-4betamethasone
ATCR03BAGlucocorticoidsATC1-4betamethasone
ATCH02ABGlucocorticoidsATC1-4betamethasone
FDASPLN0000175576CorticosteroidEPChas_epcbetamethasone
FDASPLN0000175450Corticosteroid Hormone Receptor AgonistsMOAhas_moabetamethasone
MEDRTD001623BetamethasoneCHEMhas_ingredientbetamethasone
MEDRTD001624Betamethasone ValerateCHEMhas_ingredientbetamethasone valerate
MEDRTD003876Dermatitis, AtopicDISEASEmay_treatbetamethasone valerate
MEDRTD003876Dermatitis, AtopicDISEASEmay_treatbetamethasone
MEDRTD012628Dermatitis, SeborrheicDISEASEmay_treatbetamethasone valerate
MEDRTD012628Dermatitis, SeborrheicDISEASEmay_treatbetamethasone
MEDRTD004342Drug HypersensitivityDISEASEci_withbetamethasone
MEDRTD004342Drug HypersensitivityDISEASEci_withbetamethasone valerate
MEDRTD005148Facial DermatosesDISEASEmay_treatbetamethasone
MEDRTD005148Facial DermatosesDISEASEmay_treatbetamethasone valerate
MEDRTD005533Foot DermatosesDISEASEmay_treatbetamethasone
MEDRTD005533Foot DermatosesDISEASEmay_treatbetamethasone valerate
MEDRTD006229Hand DermatosesDISEASEmay_treatbetamethasone
MEDRTD006229Hand DermatosesDISEASEmay_treatbetamethasone valerate
MEDRTD007249InflammationDISEASEmay_treatbetamethasone valerate
MEDRTD007249InflammationDISEASEmay_treatbetamethasone
MEDRTD007868Leg DermatosesDISEASEmay_treatbetamethasone valerate
MEDRTD007868Leg DermatosesDISEASEmay_treatbetamethasone
MEDRTD009181MycosesDISEASEci_withbetamethasone valerate
MEDRTD009181MycosesDISEASEci_withbetamethasone
MEDRTD011538Pruritus AniDISEASEmay_treatbetamethasone valerate
MEDRTD011538Pruritus AniDISEASEmay_treatbetamethasone
MEDRTD011565PsoriasisDISEASEmay_treatbetamethasone valerate
MEDRTD011565PsoriasisDISEASEmay_treatbetamethasone
MEDRTD016553Purpura, Thrombocytopenic, IdiopathicDISEASEci_withbetamethasone valerate
MEDRTD016553Purpura, Thrombocytopenic, IdiopathicDISEASEci_withbetamethasone
MEDRTD012536Scalp DermatosesDISEASEmay_treatbetamethasone
MEDRTD012536Scalp DermatosesDISEASEmay_treatbetamethasone valerate
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moabetamethasone valerate
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moabetamethasone
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moabetamethasone valerate
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moabetamethasone
MEDRTN0000008297Antipruritic ActivityPEhas_pebetamethasone valerate
MEDRTN0000008297Antipruritic ActivityPEhas_pebetamethasone
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_pebetamethasone valerate
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_pebetamethasone
MEDRTN0000009928Decreased Cellular MigrationPEhas_pebetamethasone valerate
MEDRTN0000009928Decreased Cellular MigrationPEhas_pebetamethasone
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_pebetamethasone
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_pebetamethasone valerate
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_pebetamethasone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_pebetamethasone valerate
MEDRTN0000008700Decreased Lysosomal FunctionPEhas_pebetamethasone
MEDRTN0000008700Decreased Lysosomal FunctionPEhas_pebetamethasone valerate
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_pebetamethasone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_pebetamethasone valerate
MEDRTN0000008841Decreased Protein SynthesisPEhas_pebetamethasone
MEDRTN0000008841Decreased Protein SynthesisPEhas_pebetamethasone valerate
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_pebetamethasone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_pebetamethasone valerate
MEDRTN0000009739Lipid Metabolism AlterationPEhas_pebetamethasone valerate
MEDRTN0000009739Lipid Metabolism AlterationPEhas_pebetamethasone

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESRXNAV_HUMAN_DRUGUS